Last Update 16 Jun 26
ASPN: Fair Outlook As Restart Progress And Refinements Shape Future Stock Performance
Analysts have lifted their Aspen Aerogels price target by $1, citing updated assumptions around discount rates, profit margins and future P/E that refine rather than overhaul their prior valuation work.
What’s in the News for Aspen Aerogels
- Aspen Aerogels began a staged restart of manufacturing operations at its East Providence, Rhode Island facility after completing mechanical, operational, and safety reviews in coordination with local, state, and federal agencies. (Key Developments)
- The company plans a deliberate, phased ramp up of production at the East Providence plant and indicates that returning the facility to full capabilities will take time. (Key Developments)
- Aspen Aerogels issued earnings guidance for the second quarter ending June 30, 2026, with expected revenue in a range of US$40 million to US$48 million and an expected net loss in a range of US$14 million to US$20 million, or US$0.17 to US$0.24 per share. (Key Developments)
- The company previously reported an explosion on April 8, 2026 at the East Providence manufacturing facility, which damaged part of the production space and led to a temporary halt in operations, with 11 employees evaluated and released from local medical facilities. (Key Developments)
- An investigation into the cause of the April 8 incident is ongoing, with preliminary reports indicating it originated in a specific high temperature oven, while Aspen Aerogels works with authorities on a plan to resume full operations. (Key Developments)
Valuation Changes
- Fair Value: Kept steady at $6.35 per share, indicating no change in the central valuation estimate for Aspen Aerogels stock in this update.
- Discount Rate: Adjusted slightly lower from 7.65% to 7.65%, reflecting a very small refinement in the risk and return assumptions used in the Aspen Aerogels valuation work.
- Revenue Growth: Left effectively unchanged at around 17.91%, suggesting the latest model run carries forward the same top line growth assumptions for Aspen Aerogels.
- Net Profit Margin: Revised slightly higher from 9.04% to about 9.10%, pointing to a modestly improved expectation for long term profitability in the updated analysis.
- Future P/E: Trimmed marginally from 19.50x to about 19.36x, indicating a small adjustment to the multiple applied to Aspen Aerogels expected earnings in the valuation framework.
Key Takeaways
- Cost reductions and process improvements are enhancing profitability and positioning the company for stronger earnings even at modest revenue levels.
- Strategic focus on EV thermal barriers and U.S.-based manufacturing aligns with regulatory trends, supporting future growth and market share expansion.
- Heavy reliance on key segments and customers, regulatory uncertainty, and ongoing margin pressures threaten growth projections and create revenue and earnings vulnerability.
Catalysts
About Aspen Aerogels- An aerogel technology company, designs, develops, manufactures, and sells aerogel materials primarily for use in the energy industrial, sustainable insulation materials, and electric vehicle (EV) markets in the United States, Canada, Asia, Europe, and Latin America.
- Aspen's cost optimization-reducing fixed costs by ~$65M and streamlining operations-substantially lowers the revenue threshold needed to achieve profitability. This greater operating leverage, combined with a stable cost structure and controlled CapEx, is set to significantly improve EBITDA and net margin even at modest revenue recovery.
- Medium-term visibility into a rebound in project-based Energy Industrial revenues (subsea/LNG), as key customers' 2025 wins and robust project backlogs are expected to drive attractive incremental revenue and high gross margins from 2026 onwards.
- Strong positioning in the EV thermal barrier market with major OEMs like GM, Stellantis, and Daimler, alongside active new quoting and prototyping activities, underpins a path toward multi-year revenue acceleration as electrification in transportation and strict emissions regulations continue to ramp up globally.
- Ongoing process improvements and increased production efficiency at the Rhode Island and Mexico facilities are driving productivity gains and gross margin expansion, further boosting long-term earnings power and resilience to lower EV production volatility.
- Domestic manufacturing capacity and flexible sourcing strategies cater to automaker preferences for U.S.-based supply and position Aspen as a preferred supplier amid intensifying regulations favoring energy efficiency and sustainability, supporting long-term revenue growth and market share gains.
Aspen Aerogels Future Earnings and Revenue Growth
Assumptions
How have these above catalysts been quantified?
- Analysts are assuming Aspen Aerogels's revenue will grow by 17.9% annually over the next 3 years.
- Analysts are not forecasting that Aspen Aerogels will become profitable in next 3 years. To represent the Analyst Price Target as a Future PE Valuation we will estimate Aspen Aerogels's profit margin will increase from -48.6% to the average US Chemicals industry of 9.1% in 3 years.
- If Aspen Aerogels's profit margin were to converge on the industry average, you could expect earnings to reach $34.4 million (and earnings per share of $0.41) by about June 2029, up from -$112.0 million today.
- In order for the above numbers to justify the price target of the analysts, the company would need to trade at a PE ratio of 19.5x on those 2029 earnings, up from -4.5x today. This future PE is lower than the current PE for the US Chemicals industry at 28.8x.
- Analysts expect the number of shares outstanding to grow by 0.63% per year for the next 3 years.
- To value all of this in today's terms, we will use a discount rate of 7.65%, as per the Simply Wall St company report.
Risks
What could happen that would invalidate this narrative?- Slower-than-expected demand recovery in the Energy Industrial segment, with continued destocking by distributors and delayed project activity (especially in subsea and LNG markets), exposes Aspen to prolonged revenue weakness and challenges the assumption of strong growth in this core business.
- High customer concentration in the EV Thermal Barrier segment, particularly reliance on GM, poses a risk to future revenues and earnings if GM's EV production or market share stalls or declines, as suggested by management noting production levels tracking IHS forecasts and emphasizing GM's outsized impact.
- Ongoing policy and regulatory volatility in key markets (notably the U.S. EV market) create uncertainty for EV adoption rates and timing of OEM launches, potentially undermining anticipated topline growth and slowing earnings improvement.
- Adjacent OEM programs, design-in activity, and new platform launches outside of current key customers (e.g., Daimler, Stellantis, ACC) have uncertain timelines or significant slippage due to shifting automaker plans and reaction to changing government incentives, posing risk to the realization of outsized growth projections for 2026-2027.
- The need for persistent R&D and capital expenditures to remain competitive combined with achieved cost reductions cycling out of the base may limit further margin expansion, while risks such as commodity price volatility and potential industry-wide pricing pressure could negatively impact future gross margins and net income.
Valuation
How have all the factors above been brought together to estimate a fair value?
- The analysts have a consensus price target of $6.35 for Aspen Aerogels based on their expectations of its future earnings growth, profit margins and other risk factors.
- However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of $8.0, and the most bearish reporting a price target of just $4.0.
- In order for you to agree with the analysts, you'd need to believe that by 2029, revenues will be $377.5 million, earnings will come to $34.4 million, and it would be trading on a PE ratio of 19.5x, assuming you use a discount rate of 7.6%.
- Given the current share price of $6.04, the analyst price target of $6.35 is 4.9% higher. The relatively low difference between the current share price and the analyst consensus price target indicates that they believe on average, the company is fairly priced.
- We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.
Have other thoughts on Aspen Aerogels?
Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.
Create NarrativeHow well do narratives help inform your perspective?
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.